- Home
- ESPR vs XRX Comparison
ESPR vs XRX Comparison
Compare ESPR & XRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ESPR
- XRX
- Stock Information
- Founded
- ESPR 2008
- XRX 1906
- Country
- ESPR United States
- XRX United States
- Employees
- ESPR N/A
- XRX N/A
- Industry
- ESPR Biotechnology: Pharmaceutical Preparations
- XRX Computer peripheral equipment
- Sector
- ESPR Health Care
- XRX Technology
- Exchange
- ESPR Nasdaq
- XRX Nasdaq
- Market Cap
- ESPR 445.6M
- XRX 481.9M
- IPO Year
- ESPR 2013
- XRX N/A
- Fundamental
- Price
- ESPR $2.76
- XRX $3.65
- Analyst Decision
- ESPR Buy
- XRX Sell
- Analyst Count
- ESPR 6
- XRX 3
- Target Price
- ESPR $6.50
- XRX $6.83
- AVG Volume (30 Days)
- ESPR 6.0M
- XRX 4.1M
- Earning Date
- ESPR 11-06-2025
- XRX 10-28-2025
- Dividend Yield
- ESPR N/A
- XRX 2.72%
- EPS Growth
- ESPR N/A
- XRX N/A
- EPS
- ESPR N/A
- XRX N/A
- Revenue
- ESPR $268,125,000.00
- XRX $6,174,000,000.00
- Revenue This Year
- ESPR $9.87
- XRX $9.19
- Revenue Next Year
- ESPR N/A
- XRX $10.35
- P/E Ratio
- ESPR N/A
- XRX N/A
- Revenue Growth
- ESPR N/A
- XRX N/A
- 52 Week Low
- ESPR $0.69
- XRX $3.45
- 52 Week High
- ESPR $3.94
- XRX $11.29
- Technical
- Relative Strength Index (RSI)
- ESPR 71.69
- XRX 38.95
- Support Level
- ESPR $2.69
- XRX $3.58
- Resistance Level
- ESPR $2.85
- XRX $3.88
- Average True Range (ATR)
- ESPR 0.17
- XRX 0.15
- MACD
- ESPR -0.00
- XRX 0.03
- Stochastic Oscillator
- ESPR 82.72
- XRX 12.75
About ESPR Esperion Therapeutics Inc.
Esperion Therapeutics Inc is a pharmaceutical company. It specializes in developing and commercializing accessible, oral, once-daily, non-statin medicines for patients struggling with elevated low-density lipoprotein cholesterol. The firm has the business of researching, developing and commercializing therapies for the treatment of patients with the elevated low-density lipoprotein cholesterol operating segment. Its products include NEXLETOL, NEXLIZET, NILEMDO and NUSTENDI. The company manages its business in one operating segment, which is the business of researching, developing and commercializing therapies for the treatment of patients with elevated LDL-C.
About XRX Xerox Holdings Corporation
Xerox Holdings Corp is an original equipment manufacturing and software company. Xerox operates in one segment--design, development, and sale of printing technology and related solutions--while deriving 60% of its revenue from the U.S. and 40% from international markets. The company is an OEM of multifunction printers, or MFPs (printers that can print, copy, and scan), focusing on large enterprise markets. Apart from equipment, the company provides post-sales services like managed print services help to bring smart servicing and efficiencies to how employers use their print/copy equipment. Xerox is attempting to enter new markets like digital print packaging solutions and printed electronics.